Live Chat

交易 Vir Biotechnology VIR

VirBiotechnology實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
date 關閉 change 更改(%): 開倉

Markets.com news

N/A
2024 Dec 10, 16:00

中文的文章

man writing inflation on line charts
Alvaro Ramos 2024 Aug 07, 16:00

No English Content Dependency

2024 Jul 31, 16:00

测试标题

Volkswagen shares drop on overnight profit warning
Georgy Istigechev 2024 Jul 10, 10:45

Volkswagen shares slide as firm mulls Brussels plant closure (ZH-TW)

聯絡方式

點差

0.05

點差(%)

0.6623 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場開放

星期二

14:31 - 20:59

星期一

14:31-20:59

星期三

14:31-20:59

星期四

14:31-20:59

星期五

14:31-20:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

1010864832

流通股份

137720000

收益日期(下一個)

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

每股盈餘

-3.93

了解有關此金融工具的詳細資訊

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

相關金融工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot
Live Chat